Although CsA treatment failed to improve muscle function in DMD patients (Kirschner et al., 2010), treatment with another cyclophilin inhibitor, Debio 025, which inhibits mPTP opening, has been shown to partially rescue the dystrophic phenotype in mdx mice (Reutenauer et al., 2008). This evidence concerns the gene PPIB and Duchenne muscular dystrophy.